US Market Research

US Market Research

Q3 "Best" Review

Dec 08, 2025
∙ Paid

Here are the stocks in the Q3 BEST watchlist I created. I didn’t create a watchlist for Q4 and as of right now I only have placed one stock in the Q1 BEST list. But, it’s still early.

These are in the order they are in the watchlist and not in preferential order.

Lyell Immunopharma is up 150%. I have flipped this once during the run. Still holding.

This post is for paid subscribers

Already a paid subscriber? Sign in
© 2025 Gravity Analytica Capital LLC · Privacy ∙ Terms ∙ Collection notice
Start your SubstackGet the app
Substack is the home for great culture